U.S. FDA revokes emergency use status of drug touted by Trump for COVID-19

U.S. FDA revokes emergency use status of drug touted by Trump for COVID-19

Reuters

Published

The U.S. Food and Drug Administration on Monday revoked the emergency use authorization for malaria drug hydroxychloroquine as a treatment for COVID-19, the use of which has been championed by U.S. President Donald Trump.

Full Article